Literature DB >> 9151988

Nuclear factor of activated T cells (NFAT) is a possible target for dexamethasone in thymocyte apoptosis.

M Wisniewska1, M Stanczyk, B Grzelakowska-Sztabert, B Kaminska.   

Abstract

Cell death plays a critical role in the generation of an effective immune system. During maturation T lymphocytes are generated, censored and eliminated in the thymus. These events are temporally associated with developmental changes in the levels of transcription factors including NFAT. The NFAT transcription factor (nuclear factor of activated T cells) is implicated in the regulation of T-lymphocyte proliferation and transcriptional activation of genes encoding lymphokines. It has been demonstrated that discontinuities in the inducibility of NFAT and AP-1 transcription factors occur during transition of immature thymocytes into cortical thymocytes which are eliminated by apoptosis. To understand the molecular basis of these developmental intrathymic changes, we studied DNA-binding activities of transcription factors during dexamethasone-induced apoptosis of immature thymocytes. We observed a specific loss of NFAT DNA-binding activity after dexamethasone treatment. It correlated with a selective disappearance of one out of two AP-1 complexes. Our data suggest that NFAT complex is a possible target in dexamethasone-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151988     DOI: 10.1006/cbir.1996.0124

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism.

Authors:  Alessandra Pires Duarte; Carolina Cavaliéri Gomes; Ricardo Santiago Gomez; Fabrício Rezende Amaral
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

Review 2.  Glucocorticoid treatment of primary CNS lymphoma.

Authors:  M Weller
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

3.  Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease.

Authors:  K Thiele; A Bierhaus; F Autschbach; M Hofmann; W Stremmel; H Thiele; R Ziegler; P P Nawroth
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.